PLOT NO:60 A, JAWAHARLAL NEHRU PHARMA CITY, PARAWADA, VISAKHAPATNAM – 531019, ANDHRA PRADESH, INDIA
Api

Active Pharmaceutical Ingredients

NAME OF THE PRODUCT CAS NO. THERAPEUTIC USE DMF STATUS GMP CERTIFICATION
Atracurium Besylate BP/Ph.Eur./USP/IP 64228-79-1 Neuromuscular Blocking Agent Available WHO, WC
Betahistine Dihydrochloride BP/Ph.Eur./USP/IP 5579-84-0 Anti-Vertigo Available Available
Biperiden Hydrochloride BP/Ph.Eur./USP/IP 1235-82-1 Anti-Parkinsonian DMF available WHO
Bisoprolol Fumarate BP/Ph.Eur./USP/IP/JP 104344-23-2 Anti-Hypertensive DMF available WHO, WC
Cisatracurium Besylate BP/Ph.Eur./USP/CP 96946-42-8 Neuromuscular Blocking Agent DMF available Available
Deferasirox Ph.Eur./IP/IH 201530-41-8 Iron Chelator DMF available WHO
Fingolimod Hydrochloride IH 162359-56-0 Multiple Sclerosis Therapy DMF available Available
Mirabegron IH 223673-61-8 Overactive Bladder Therapy DMF available WHO
Noscapine BP/Ph.Eur./USP/CP/IP/JP 128-62-1 Anti-Tussive DMF available WHO, WC, PMDA, NMPA
Noscapine Hydrochloride BP/Ph.Eur./JP 912-60-7 Anti-Tussive DMF available WHO, WC, PMDA
Oseltamivir Phosphate BP/Ph.Eur./USP/IP/CP 204255-11-8 Anti-Viral (Influenza) DMF available WHO, WC
Papaverine Hydrochloride BP/Ph.Eur./USP/IP/JP/CP 61-25-6 Anti-Spasmodic DMF available WHO, WC, PMDA, NMPA
Podophyllum Resin BP 9000-55-9 Anti-Wart DMF not available Available
Podophyllotoxin IH 518-28-5 Anti-Wart DMF not available Available
Risedronate Sodium BP/Ph.Eur./USP/IP 353228-19-0 Anti-Osteoporotic DMF available WHO, WC
Rocuronium Bromide BP/Ph.Eur./USP/IP 119302-91-9 Neuromuscular Blocking Agent DMF available WHO, WC
Tetrabenazine IH 58-46-8 Anti-Chorea (Huntington's) DMF available WHO, WC

Table Legend:

  • WC = EU Written Confirmation (European regulatory acceptance)
  • PMDA = Japan Pharmaceuticals and Medical Devices Agency (foreign manufacturer accreditation)
  • NMPA = China National Medical Products Administration (foreign manufacturer accreditation)

NOTE:

  • All transactions are carried out in conformity with Patent Laws applicable in the user country.
  • Responsibility with respect to third party's Patent rights in a specific country lies exclusively with the buyer.